Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04597671
Status:
RECRUITING
Last Update Posted:
2023-06-05
First Post:
2020-09-24
Brief Title:
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC NVALT28
Sponsor:
Association NVALT Studies
Organization:
Dutch Society of Physicians for Pulmonology and Tuberculosis
Organization Data
Organization:
Dutch Society of Physicians for Pulmonology and Tuberculosis
Class:
OTHER
Study ID:
NVALT28
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Association NVALT Studies
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None